Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Betamethasone prices in Germany, the highest-cost reporting region, rose 6.1% in H1 2026, recovering from USD 394.0/KG in Q1 to USD 418.0/KG by Q2 as firmer corticosteroid synthesis intermediate costs and recovering pharmaceutical formulation and hospital procurement demand reversed the brief Q1 API cost softening. Globally, the average rose from USD 290.6/KG in Q1 to USD 308.0/KG in Q2, a 6.0% gain. For H2 2026, a global average of USD 312.0-344.0/KG is expected, with continued firming on Middle East supply disruptions and growing dermatology, respiratory, and rheumatology sector demand.
Betamethasone is a potent synthetic fluorinated glucocorticoid corticosteroid produced through a multi-step chemical synthesis starting from plant-derived steroidal precursors, primarily diosgenin extracted from Dioscorea wild yam species or phytosterols from soybean or tall oil. The synthesis involves a complex sequence of oxidation, reduction, fluorination, and esterification reactions to produce the active pharmaceutical ingredient in various forms including betamethasone valerate, betamethasone dipropionate, and betamethasone sodium phosphate. The largest pull comes from topical dermatology formulations, where betamethasone creams, ointments, and lotions are widely prescribed for eczema, psoriasis, and allergic dermatitis management. Additional demand comes from injectable formulations for rheumatoid arthritis and antenatal foetal lung maturation therapy, ophthalmic formulations for inflammatory eye conditions, inhalation formulations for asthma management, and combination antibiotic-corticosteroid ear and nasal drop products. Phytosterol and diosgenin synthesis precursor costs, pharmaceutical formulation sector demand, and regional corticosteroid API production capacity all feed into the price.
The balance of supply and demand for betamethasone through H2 2026 leans moderately firm. Steroid synthesis intermediate and phytosterol precursor costs firmed from Middle East chemical supply chain disruptions. Dermatology, antenatal, and respiratory corticosteroid formulation demand is growing with expanding healthcare access and chronic disease management markets across South and Southeast Asia.
The main upside risk is a sustained steroidal synthesis intermediate cost increase alongside accelerating dermatology and antenatal healthcare demand in emerging markets. The main downside risk is continued Chinese corticosteroid API production surplus and competitive export pricing that limits the global price recovery.
| Region | 2026 Price Range (USD/KG) | Outlook |
| Global Average | 312.0 - 344.0 | Synthesis cost firming and pharma demand support |
| United States | 332.0 - 364.0 | Steady dermatology and hospital demand holds firm |
| China | 222.0 - 254.0 | Large API capacity keeps it the most affordable |
| Germany | 420.0 - 452.0 | High synthesis and energy costs keep it the most expensive |
| India | 304.0 - 336.0 | Growing pharma demand holds a firm middle range |
US betamethasone prices averaged USD 348.0/KG in Q2 2026, up 6.1% from USD 328.0/KG in Q1 2026. Firmer steroidal synthesis intermediate costs and recovering dermatology and hospital formulation procurement lifted the market. Spring pharmaceutical contract cycles maintained consistent buying through the quarter.
Why did the price of Betamethasone change in Q2 2026 in the United States?
Firmer phytosterol and steroidal synthesis intermediate costs raised the multi-step corticosteroid production cost floor. Dermatology cream and ointment formulation and hospital injectable procurement lifted buying from API suppliers. Antenatal foetal lung maturation therapy and respiratory inhaler sector demand provided additional consistent buying.
Chinese betamethasone prices averaged USD 233.5/KG in Q2 2026, up 5.9% from USD 220.5/KG in Q1 2026, the lowest among the tracked markets. Spring pharmaceutical formulation export procurement and recovering dermatology sector demand lifted buying. Firmer domestic phytosterol costs raised the production floor despite large domestic API capacity.
Why did the price of Betamethasone change in Q2 2026 in China?
Spring pharmaceutical formulation export and domestic dermatology demand lifted procurement from domestic API producers. Firmer domestic phytosterol and synthesis intermediate costs raised the production cost floor. Large domestic corticosteroid API capacity kept China the most affordable source.
German betamethasone prices averaged USD 418.0/KG in Q2 2026, up 6.1% from USD 394.0/KG in Q1 2026, the highest among the tracked markets. Higher synthesis intermediate and energy costs elevated European API production economics. Recovering dermatology, respiratory, and hospital formulation demand maintained consistent buying.
Why did the price of Betamethasone change in Q2 2026 in Germany?
Higher steroidal synthesis intermediate and energy costs elevated European corticosteroid API production economics. Middle East supply disruptions added cost premiums to phytosterol precursor supply chains. Recovering dermatology formulation, hospital injectable, and respiratory therapy demand maintained consistent procurement.
Indian betamethasone prices averaged USD 320.0/KG in Q2 2026, up 6.1% from USD 301.5/KG in Q1 2026. Growing dermatology and hospital formulation demand supported buying. Firmer import-linked synthesis intermediate costs raised the production floor through the quarter.
Why did the price of Betamethasone change in Q2 2026 in India?
Growing dermatology cream, injectable, and combination product formulation demand lifted procurement from domestic API producers. Firmer import-linked phytosterol and synthesis intermediate costs raised the production floor. Middle East freight premiums elevated the landed cost of imported betamethasone API and precursors.
US betamethasone prices averaged USD 328.0/KG in Q1 2026, declining from Q4 2025. Softer synthesis intermediate costs and year-end pharmaceutical procurement moderation eased the market near USD 328.0/KG.
Why did the price of Betamethasone change in Q1 2026 in the United States?
Softer phytosterol and synthesis intermediate costs reduced the production cost floor. Year-end pharmaceutical and hospital procurement moderation lowered buying urgency. The market eased to USD 328.0/KG before the Q2 2026 spring pharmaceutical contract recovery.
Chinese prices averaged USD 220.5/KG in Q1 2026, declining from Q4 2025. Softer synthesis intermediate costs and post-Lunar New Year procurement moderation held the market near USD 220.5/KG.
Why did the price of Betamethasone change in Q1 2026 in China?
Softer domestic phytosterol and synthesis intermediate costs eased the production floor. Post-Lunar New Year pharmaceutical procurement moderation reduced export urgency. Large domestic capacity maintained adequate supply near USD 220.5/KG.
German prices averaged USD 394.0/KG in Q1 2026, declining from Q4 2025. Softer synthesis intermediate costs and seasonal pharmaceutical procurement moderation eased the market near USD 394.0/KG.
Why did the price of Betamethasone change in Q1 2026 in Germany?
Softer steroidal synthesis intermediate costs eased the European production cost floor. Year-end pharmaceutical and hospital procurement moderation reduced buying. The market eased to USD 394.0/KG before the Q2 spring formulation procurement recovery.
Indian prices averaged USD 301.5/KG in Q1 2026, declining on the quarter. Softer import-linked synthesis costs and post-holiday procurement moderation held the market near USD 301.5/KG.
Why did the price of Betamethasone change in Q1 2026 in India?
Softer import-linked synthesis intermediate costs eased the production floor. Post-holiday pharmaceutical procurement moderation reduced urgency. The market eased to USD 301.5/KG before the Q2 spring pharmaceutical season recovery.
Global betamethasone prices rose through Q3 and Q4 2025 on the pharmaceutical formulation season, dipped in Q1 2026 on synthesis intermediate cost softening, then surged in Q2 2026 on recovering demand and firmer precursor costs. The average rose from USD 285.0/KG in Q2 2025 to USD 290.7/KG in Q3 and USD 296.5/KG in Q4, eased to USD 290.6/KG in Q1 2026, then surged to USD 308.0/KG in Q2 2026, a net gain of about 8.1% over the window. Steroidal synthesis intermediate cycles and pharmaceutical formulation sector demand drove the pattern.
| Quarter | Price (USD/KG) | QoQ Change | Direction |
| Q2 2026 | 308.0 | +6.0% | ↑ Rising |
| Q1 2026 | 290.6 | -2.0% | ↓ Falling |
| Q4 2025 | 296.5 | +2.0% | ↑ Rising |
| Q3 2025 | 290.7 | +2.0% | ↑ Rising |
| Q2 2025 | 285.0 | - | - Stable |
| Q3 2026 | In Progress | - | - In Progress |
Betamethasone prices firmed through H2 2025 on the pharmaceutical formulation season. The global average opened at USD 282.0/KG in Q1 2025 and closed near USD 296.5/KG in Q4, a full-year gain of about 5.1%. Consistent dermatology and hospital formulation demand and firming phytosterol precursor costs supported the H2 uptick.
US prices firmed from about USD 325.0/KG in Q1 2025 to USD 335.0/KG by Q4, a gain of 3.1%. Consistent dermatology and hospital formulation demand supported the upward trend through the year.
Chinese prices fell from roughly USD 228.0/KG in Q1 2025 to USD 225.0/KG by Q4, a decline of 1.3%. Large domestic corticosteroid API production capacity and competitive export pricing maintained downward pressure throughout the year.
German prices firmed from about USD 388.0/KG in Q1 2025 to USD 402.0/KG by Q4, a gain of 3.6%, the strongest in the dataset. Consistent dermatology, respiratory, and hospital formulation demand and firm synthesis and energy costs supported the market throughout the year.
Indian prices firmed from roughly USD 298.0/KG in Q1 2025 to USD 308.0/KG by Q4, a gain of 3.4%. Growing dermatology and antenatal therapy formulation demand drove the consistent firming through the year.
Expert Market Research: Your Source for Real-Time Betamethasone Price Intelligence
Expert Market Research tracks betamethasone prices continuously across every major producing and consuming region. The team traces causation through phytosterol and steroidal synthesis intermediate economics, pharmaceutical formulation sector demand cycles, and regional corticosteroid API production capacity. Contact Expert Market Research today for betamethasone pricing data, bespoke market analysis, and strategic procurement advisory.
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Topical dermatology formulations for eczema, psoriasis, and allergic dermatitis management take the largest share. Injectable formulations for rheumatoid arthritis and antenatal foetal lung maturation therapy, ophthalmic anti-inflammatory formulations, asthma inhalation therapy, and combination antibiotic-corticosteroid ear and nasal products also consume significant volumes globally.
The Q2 2026 average was USD 348.0/KG in the United States, USD 233.5/KG in China, USD 418.0/KG in Germany, and USD 320.0/KG in India. Germany remains the highest-priced market.
The global average rose from USD 290.6/KG in Q1 to about USD 308.0/KG in Q2, a gain of around 6.0%. Recovering pharmaceutical demand and firmer synthesis intermediate costs drove the H1 rebound from the Q1 API cost softening.
Softer phytosterol and steroidal synthesis intermediate costs reduced the production cost floor. Year-end pharmaceutical and hospital procurement moderation reduced buying urgency before the Q2 spring formulation season recovery.
The global average is expected in the USD 312.0 to 344.0/KG range for H2 2026, with continued firming as synthesis intermediate costs stay elevated and dermatology and hospital formulation demand grows across emerging markets.
Germany sits highest on synthesis and energy costs, the United States and India hold a firm middle on pharmaceutical and hospital demand, and China prices lowest on large domestic corticosteroid API production capacity.
This report is updated monthly. For real-time pricing intelligence, contact the Expert Market Research team directly.
Prices respond mainly to phytosterol and diosgenin precursor costs, pharmaceutical formulation season cycles, and hospital and dermatology sector demand. Chinese API production discipline and Middle East chemical supply events are key signals.
Asia Pacific leads with China holding the largest corticosteroid API synthesis capacity, followed by India and Europe. Any phytosterol or synthesis intermediate cost shift ripples across betamethasone markets within one to two quarters.
Buyers can use quarterly trends and forecasts to time pharmaceutical formulation contracts around API production season cycles, build cover when phytosterol signals tightening, and monitor Chinese corticosteroid API production output as the primary supply signal.
One Year Subscription
One Year Subscription
USD 799
USD 699
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.